This article "2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial" is published in BMJ ADC Fetal and Neonatal. Author:Paul ClarkeJournal:BMJ ADC Fetal and NeonatalYear:2023Podcast type:ExpertThe authors are Paul Clarke, Aung Soe, Amy Nichols, Helen Harizaj, Mark A Webber, Louise Linsell, Jennifer L Bell, Catherine Tremlett, Priyadarsini Muthukumar, Santosh Pattnayak, Christopher Partlett, Andrew King, Ed Juszczak, Paul T HeathAffiliations:Neonatal Intensive Care Unit, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UKNorwich Medical School, University of East Anglia, Norwich, Norfolk, UK Quadram Institute, Norwich Research Park, Colney Lane, Norwich NR4 7UQ, UKNational Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK Department of Microbiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UKCentre for Neonatal and Paediatric Infection, Infection and Immunity, Saint George’s University of London, London, UK

Ver todos los episodios